Our team of experienced drug developers and company builders partner with a new generation of passionate, business-minded scientists to foster each therapeutic program from discovery through clinical trials.
board members
Charles Homcy
Richard Scheller
Ali Satvat
James Momtazee
Neil Kumar
company
Adam Shaywitz
Agis Kydonieus
Ai Li
Alan Ji
Ali Satvat
Alix Alderman
Amy Thompson
Ananth Sridhar
Andrea Orozco
Andreas Betz
Angelos Dovletoglou
Anjali Pandey
Anna Maciag
Anna Wade
April Yang
Asha Rajagopal
Ashley Cooper
Athiwat Hutchaleelaha
Baird Ruch
Becky Dabora
Ben Neel
Benjamin Collman
Brian Eater
Brian Metcalf
Brian Stephenson
Bruno Gagnon
Cameron Turtle
Carina Castilla
Carl Dambkowski
Carolina Brekke
Chao Cui
Charles Homcy
Christine Siu
Christopher Brown
Christopher Foo
Chuck Nomides
Chun Jiang
Clayton Beard
Corey Woolfolk
Craig Berman
Curtis Scribner
Dan Gretler
Dan Hoth
Daniel Genov
Daniel Mulreany
Daniela Rogoff
Danny Joh
David Hinds
David Martin
David Nader
David Rintell
David Scott
David Smith
David Turner
Dawn Hill
Dawn Toronto
Dennis Adair
Donna Cabral-Lilly
Doris Davis
Dwight Nissley
Elizabeth Vadas
Eric Chen
Eric David
Eric Gomez
Ervin Epstein
Evangeline de Guzman
Franco Valle
Frank McCormick
Frank Rockhold
Fred Porter
Fred Reno
Gang Li
Gary Mansfield
George Koshy
Gerd Kochendoerfer
Hannah Shen
Hans Goldberg
Hao Chen
Harris Soifer
Hector Rodriguez
Hernan Fuentes
Holly Condon
Holly Maxfield
Holly Prentice
Hoyoung Huh
Hua Deng
Isabella Graef
Jacki Fontaine
James Andrew Whitney
James Kanter
James Momtazee
Jean Tang
Jeanette Lisac
Jenelle Lin
Jennifer Bond
Jeremy Rouse
Jesper Jernelius
Jessica Meidinger
Jonathan Barr
Jonathan Fox
partners
investors
This page links to Internet sites operated and maintained by entities other than BridgeBio and its affiliates. BridgeBio is not responsible for the content available on any third-party Internet sites linked to this website. BridgeBio provides these links as a convenience to users, but such links do not imply BridgeBio’s endorsement of material on any linked third-party site.
BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
Join Us